Anzeige
Mehr »
Login
Freitag, 16.04.2021 Börsentäglich über 12.000 News von 660 internationalen Medien
Codename: Siebzehntausend! Rritual landet den "Super-Vertrag"!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 509722 ISIN: SE0000722365 Ticker-Symbol: OMAX 
Berlin
16.04.21
14:13 Uhr
0,343 Euro
+0,002
+0,62 %
Branche
Pharma
Aktienmarkt
General Standard
1-Jahres-Chart
OASMIA PHARMACEUTICAL AB Chart 1 Jahr
5-Tage-Chart
OASMIA PHARMACEUTICAL AB 5-Tage-Chart

Aktuelle News zur OASMIA PHARMACEUTICAL Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
12.03.Oasmia Pharmaceutical - Onwards and upwards195Oasmia is at a major inflection point as it focuses on its transformation into an R&D-driven, specialty pharma company, with commercially available assets. During 2020, with new management at the helm...
► Artikel lesen
OASMIA PHARMACEUTICAL Aktie jetzt für 0€ handeln
01.03.Kazia Therapeutics licenses drug candidate to Oasmia1
01.03.Kazia Therapeutics Licenses Cantrixil To Oasmia Pharmaceutical For Ovarian Cancer2
01.03.Kazia Licenses Cantrixil, a Clinical-stage, First-in-class Ovarian Cancer Drug Candidate, to Oasmia Pharmacetical AB223SYDNEY, March 1, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it has entered...
► Artikel lesen
01.03.KAZIA THERAPEUTICS LIMITED: Kazia licenses Cantrixil to Oasmia3
17.12.20Oasmia Pharmaceutical - Clarity on pathway to US approval169Oasmia's H1 FY21 results highlight recent developments made to realign the business. In December, global partner Elevar Therapeutics announced it had concluded discussions with the FDA on the pathway...
► Artikel lesen
14.10.20Nasdaq Nordic: Nasdaq Stockholm orders Oasmia Pharmaceutical AB to pay a fine corresponding to fifteen annual fees265Stockholm, October 14, 2020 - The Disciplinary Committee of Nasdaq Stockholm has found that Oasmia Pharmaceutical AB ("Oasmia Pharmaceutical" or the "Company") has breached the rules of Nasdaq Stockholm...
► Artikel lesen
09.09.20Edison Investment Research Limited: Edison issues initiation on Oasmia Pharmaceutical (OASM)265DJ Edison Investment Research Limited: Edison issues initiation on Oasmia Pharmaceutical (OASM) Edison Investment Research Limited Edison Investment Research Limited: Edison issues initiation...
► Artikel lesen
09.09.20Oasmia Pharmaceutical - An appealing metamorphosis235Oasmia is a specialty pharma company focused on developing improved formulations of well-established cancer drugs through its proprietary XR-17 platform technology. Its technology has received validation...
► Artikel lesen
9 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1